GastroenterologyGenomic Profiling of Primary Gastric Tumors Predicts Recurrence Patterns and Survival Outcomes
MedXY Editorial Team
Highlight
- Alterations in KRAS and PIK3CA genes independently associate with worse disease-free survival in resected gastric cancer.
- Distinct genomic characteristics differentiate patterns of recurrence: hematogenous, peritoneal, and lymphatic metastases.
- Hematogenous recurrence correlates with increased chromosomal instability and cell cycle regulatory gene alterations.
- Bony metastases arise predominantly from genomically stable, diffuse-type tumors, highlighting histologic-genomic interplay.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
